Journal profile · Medicine-Medicine (all)
Serbian Journal of Experimental and Clinical Research
ISSN 1820-8665 · eISSN 2956-2090 · University of Kragujevac · Poland
Serbian Journal of Experimental and Clinical Research: fully open access; no APC; review about 6 weeks (community reports); acceptance rate 30% (journal website); 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Serbian Journal of Experimental and Clinical Research is published by University of Kragujevac. By OpenAlex counts of its recent articles, its largest topics are Antioxidant Activity and Oxidative Stress, Dialysis and Renal Disease Management and Nitric Oxide and Endothelin Effects, together about 21% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
EABR. Experimental and Applied Biomedical Research former Serbian Journal of Experimental and Clinical Research is a peer-reviewed, open access journal which publishes original research articles, reviews, case reports and letters to the editor in all areas of the biomedical sciences that have not been published previously. The journal comprises both basic and clinical research in the field of biomedicine. Current acceptance rate is around 30%. EABR was founded in 2000 under the name Medicus and over more than two decades has grown into one of the leading national journals in the field of biomedical sciences. EABR. Experimental and Applied Biomedical Research is owned and published by Faculty of Medical Sciences, University of Kragujevac. The journal adheres to the policies of the International Committee of Medical Journal Editors (ICMJE) and publishing ethics guidelines provided by the Committee on Publication Ethics (COPE).EABR publishes papers from all fields of biomedical science and practice in form of original papers, short communications, reviews/meta-analyses, case reports, medical history articles, personal views, letters to the editor, reports from scientific meetings that have not been published previously. EABR is an Open Access Journal and it is published four times a year.The first issue of EABR was published in March 2000.EABR is owned and published by Faculty of Medical Sciences University of Kragujevac. However, Editors have full academic freedom and authority for determining the editorial content of the journal, according to their scientific, professional and ethical judgment.Editorial policy and decision making follow procedures which are endeavoring to ensure scientific credibility of published content, confidentiality and integrity of authors, reviewers, and review process, protection of patients’ rights to privacy and disclosing of conflict of interests.Copyright PolicyThe journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users. All articles published in EABR. Experimental and Applied Biomedical Research are published and distributed under the terms of the CC BY-NC-ND 4.0 License, hich permits reproduction, distribution, derives and commercial use, provided the original work is properly cited and authors and publisher are properly identified. After copyright assignment, copyrights to published articles are transfered tothe owner and publisher of th
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (all)
Editor-in-chief Olgica MihaljevicPublisher website
Editorial board by country: none in mainland China; most named Serbia 4, United States 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antioxidant Activity and Oxidative StressMedicine9.6%
- Dialysis and Renal Disease ManagementMedicine6.1%
- Nitric Oxide and Endothelin EffectsMedicine5.3%
- Metal complexes synthesis and propertiesMedicine5%
- Exercise and Physiological ResponsesMedicine5%
- Medicinal Plant ResearchAgricultural and Biological Sciences5%
- Cardiovascular Function and Risk FactorsMedicine4.3%
- Cardiac Ischemia and ReperfusionMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q3 | 609/830 | 26th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- CiteScore (publisher)
- 0.6Publisher website ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.14LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 38OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 600 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 77 |
| 2025 | 0 | 0 | 149 |
| 2024 | 0 | 0 | 178 |
| 2023 | 0 | 0 | 179 |
| 2022 | 31 | 31 | 177 |
| 2021 | 32 | 32 | 173 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Acceptance rate (publisher)
- 30%Publisher website ·
- Peer review
- Double blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright Copyright Policy
The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users. All articles published in EABR. Experimental and Applied Biomedical Research are published and distributed under the terms of the CC BY-NC-ND 4.0 License, hich permits reproduction, distribution, derives and commercial use, provided the original work…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- University of Kragujevac
- Country or region
- Poland
- Language
- English
- ISSN
- 1820-8665
- Print ISSN
- 2956-0454
- Electronic ISSN
- 2956-2090
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Serbian Journal of Experimental and Clinical Research
How long does peer review take at Serbian Journal of Experimental and Clinical Research?
Authors report an average review time of about 6 weeks; the journal's website gives an acceptance rate of 30%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Serbian Journal of Experimental and Clinical Research based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Serbia (4) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Serbian Journal of Experimental and Clinical Research?
According to LetPub and DOAJ records, Serbian Journal of Experimental and Clinical Research is indexed in Scopus.
Is Serbian Journal of Experimental and Clinical Research open access, and what is the APC?
Serbian Journal of Experimental and Clinical Research is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .